Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.

Also called NCT07889531

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 256 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07889531
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07889531. Randomized; quadruple masking; primary purpose prevention. Start 2026-10-10 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease
Condition
Moya Moya Disease
Condition
Moyamoya Syndrome
Intervention (Device)
Standard Remote Ischemic Preconditioning
Intervention (Device)
Sham Remote Ischemic Preconditioning
Lead sponsor
Beijing Tiantan Hospital (class: other)
Collaborator
Henan Provincial People's Hospital (class: other)
Collaborator
The Fifth Medical Center of the PLA General Hospital (class: not stated)
Collaborator
The First Affiliated Hospital of Zhengzhou University (class: other)
Collaborator
The First Affiliated Hospital of Nanchang University (class: other)

Record details

Record id
cardio:ct-nct07889531
Content hash
52108bf60e2607dd36ba6d28f58e8be3c79f39fe3d97ebd6d4b21d697d80e735